Literature DB >> 18575893

Cell-type-specific level of DNA nucleotide excision repair in primary human mammary and ovarian epithelial cell cultures.

Jean J Latimer1, Jennifer M Johnson, Tiffany D Miles, Jason M Dimsdale, Robert P Edwards, Joseph L Kelley, Stephen G Grant.   

Abstract

DNA repair, a fundamental function of cellular metabolism, has long been presumed to be constitutive and equivalent in all cells. However, we have previously shown that normal levels of nucleotide excision repair (NER) can vary by 20-fold in a tissue-specific pattern. We have now successfully established primary cultures of normal ovarian tissue from seven women by using a novel culture system originally developed for breast epithelial cells. Epithelial cells in these cultures aggregated to form three-dimensional structures called "attached ovarian epispheres". The availability of these actively proliferating cell cultures allowed us to measure NER functionally and quantitatively by the unscheduled DNA synthesis (UDS) assay, a clinical test used to diagnose constitutive deficiencies in NER capacity. We determined that ovarian epithelial cells manifested an intermediate level of NER capacity in humans, viz., only 25% of that of foreskin fibroblasts, but still 2.5-fold higher than that of peripheral blood lymphocytes. This level of DNA repair capacity was indistinguishable from that of normal breast epithelial cells, suggesting that it might be characteristic of the epithelial cell type. Similar levels of NER activity were observed in cultures established from a disease-free known carrier of a BRCA1 truncation mutation, consistent with previous normal results shown in breast epithelium and blood lymphocytes. These results establish that at least three "normal" levels of such DNA repair occur in human tissues, and that NER capacity is epigenetically regulated during cell differentiation and development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18575893      PMCID: PMC4301738          DOI: 10.1007/s00441-008-0645-1

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  28 in total

Review 1.  Nucleotide excision repair and its interplay with transcription.

Authors:  Anneke van Hoffen; A S Balajee; Albert A van Zeeland; Leon H F Mullenders
Journal:  Toxicology       Date:  2003-11-15       Impact factor: 4.221

Review 2.  Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy.

Authors:  E Reed
Journal:  Cancer Treat Rev       Date:  1998-10       Impact factor: 12.111

3.  Elevated DNA excision repair capacity in the extraembryonic mesoderm of the midgestation mouse embryo.

Authors:  J J Latimer; M L Hultner; J E Cleaver; R A Pedersen
Journal:  Exp Cell Res       Date:  1996-10-10       Impact factor: 3.905

4.  DNA repair capacity of lymphoblastoid cell lines from sisters discordant for breast cancer.

Authors:  David O Kennedy; Meenakshi Agrawal; Jing Shen; Mary Beth Terry; Fang Fang Zhang; Ruby T Senie; Grazyna Motykiewicz; Regina M Santella
Journal:  J Natl Cancer Inst       Date:  2005-01-19       Impact factor: 13.506

5.  Xeroderma pigmentosum with recurrent infiltrating ductal carcinoma of breast.

Authors:  Y Milo; A A Deutsch; S Zahavi; A Ingber; R Reiss
Journal:  Postgrad Med J       Date:  1994-03       Impact factor: 2.401

6.  Unique tissue-specific level of DNA nucleotide excision repair in primary human mammary epithelial cultures.

Authors:  Jean J Latimer; Tariq Nazir; Lisa C Flowers; Michael J Forlenza; Kelly Beaudry-Rodgers; Crystal M Kelly; Julie A Conte; Kenneth Shestak; Amal Kanbour-Shakir; Stephen G Grant
Journal:  Exp Cell Res       Date:  2003-11-15       Impact factor: 3.905

Review 7.  BRCA1 gene in breast cancer.

Authors:  Eliot M Rosen; Saijun Fan; Richard G Pestell; Itzhak D Goldberg
Journal:  J Cell Physiol       Date:  2003-07       Impact factor: 6.384

Review 8.  Genetics of breast and ovarian cancer.

Authors:  S A Narod
Journal:  Br Med Bull       Date:  1994-07       Impact factor: 4.291

9.  BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair.

Authors:  Anne-Renee Hartman; James M Ford
Journal:  Nat Genet       Date:  2002-08-26       Impact factor: 38.330

10.  Haploinsufficiency for BRCA1 is associated with normal levels of DNA nucleotide excision repair in breast tissue and blood lymphocytes.

Authors:  Jean J Latimer; Wendy S Rubinstein; Jennifer M Johnson; Amal Kanbour-Shakir; Victor G Vogel; Stephen G Grant
Journal:  BMC Med Genet       Date:  2005-06-14       Impact factor: 2.103

View more
  7 in total

1.  Regulation and disregulation of mammalian nucleotide excision repair: a pathway to nongermline breast carcinogenesis.

Authors:  Jean J Latimer; Vongai J Majekwana; Yashira R Pabón-Padín; Manasi R Pimpley; Stephen G Grant
Journal:  Photochem Photobiol       Date:  2014-12-19       Impact factor: 3.421

2.  Nucleotide excision repair deficiency is intrinsic in sporadic stage I breast cancer.

Authors:  Jean J Latimer; Jennifer M Johnson; Crystal M Kelly; Tiffany D Miles; Kelly A Beaudry-Rodgers; Nancy A Lalanne; Victor G Vogel; Amal Kanbour-Shakir; Joseph L Kelley; Ronald R Johnson; Stephen G Grant
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-30       Impact factor: 11.205

3.  Functional profiling of nucleotide Excision repair in breast cancer.

Authors:  Anne S Rajkumar-Calkins; Raphael Szalat; Matija Dreze; Iman Khan; Zoë Frazier; Elizaveta Reznichenkov; Mathew R Schnorenberg; Yi-Fang Tsai; Huy Nguyen; Bose Kochupurakkal; Alan D D'Andrea; Geoffrey I Shapiro; Jean-Bernard Lazaro; Kent W Mouw
Journal:  DNA Repair (Amst)       Date:  2019-08-30

4.  Unscheduled DNA synthesis: the clinical and functional assay for global genomic DNA nucleotide excision repair.

Authors:  Jean J Latimer; Crystal M Kelly
Journal:  Methods Mol Biol       Date:  2014

5.  Analysis of actively transcribed DNA repair using a transfection-based system.

Authors:  Jean J Latimer
Journal:  Methods Mol Biol       Date:  2014

6.  Preliminary Evidence for a Hormetic Effect on DNA Nucleotide Excision Repair in Veterans with Gulf War Illness.

Authors:  Jean J Latimer; Abdullah Alhamed; Stefanie Sveiven; Ali Almutairy; Nancy G Klimas; Maria Abreu; Kimberly Sullivan; Stephen G Grant
Journal:  Mil Med       Date:  2020-02-13       Impact factor: 1.437

7.  Co-administering Melatonin With an Estradiol-Progesterone Menopausal Hormone Therapy Represses Mammary Cancer Development in a Mouse Model of HER2-Positive Breast Cancer.

Authors:  Balasunder R Dodda; Corry D Bondi; Mahmud Hasan; William P Clafshenkel; Katie M Gallagher; Mary P Kotlarczyk; Shalini Sethi; Ethan Buszko; Jean J Latimer; J Mark Cline; Paula A Witt-Enderby; Vicki L Davis
Journal:  Front Oncol       Date:  2019-07-09       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.